CardioCell

DRUG2 trials

Sponsors

John Paul II Hospital, Krakow

Conditions

Critical Limb IschemiaHeart Failure

Phase 2

Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)

CompletedNCT03418233

John Paul II Hospital, KrakowHeart Failure

Start: 2018-04-19End: 2021-03-31Updated: 2021-04-09

Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)

John Paul II Hospital, KrakowCritical Limb Ischemia

Start: 2018-04-19End: 2021-09-30Updated: 2021-04-09

Related Papers

P774Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

European Heart Journal2019-10-011 citations